Table 4

Results of DAVF treatment n-BCA versus ONYX

Liquid embolic agentNo of DAVFInitial angio occlusionRecDurable angio occlusionSurgical occlusion post-INRInc
n-BCA21707113
ONYX3529127 (+2 pending f/u angio)42
  • Angio, angiogram; DAVF, dural arteriovenous fistula; Inc, incomplete; n-BCA, n-butyl-2-cyanoacrylate; ONYX, ethylene vinyl alcohol copolymer; post-INR, post embolization; Rec, recurrence.